Zejula 200 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FJE41
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,794
Award facts
- Contract value 100% obligated
- $11,794.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11.8K delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of ZEJULA 200 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with a completion deadline of August 21, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. ZEJULA (niraparib) is a poly(ADP-ribose) polymerase inhibitor used in oncology treatment, reflecting the Defense Logistics Agency's ongoing pharmaceutical procurement needs for military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $1 billion vehicle valued through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp regularly fulfills federal medical supply requirements through competitively awarded contracts spanning multiple therapeutic domains. The company's extensive federal contract portfolio demonstrates its capability to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with brand-name medications, generics, vaccines, and specialized medical supplies.
Quick answers
Who was awarded contract SPE2DB25FJE41?
SPE2DB25FJE41 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 31, 2025.
How much is contract SPE2DB25FJE41 worth?
The government has obligated $11,794 on SPE2DB25FJE41.
Is contract SPE2DB25FJE41 an order under another contract?
Yes. SPE2DB25FJE41 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJE41 competed?
The extent of competition for SPE2DB25FJE41 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award